CA2285852C - Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline - Google Patents

Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline Download PDF

Info

Publication number
CA2285852C
CA2285852C CA 2285852 CA2285852A CA2285852C CA 2285852 C CA2285852 C CA 2285852C CA 2285852 CA2285852 CA 2285852 CA 2285852 A CA2285852 A CA 2285852A CA 2285852 C CA2285852 C CA 2285852C
Authority
CA
Canada
Prior art keywords
lisinopril
disodium
microcrystalline cellulose
water
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2285852
Other languages
English (en)
Other versions
CA2285852A1 (fr
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2285852 priority Critical patent/CA2285852C/fr
Publication of CA2285852A1 publication Critical patent/CA2285852A1/fr
Application granted granted Critical
Publication of CA2285852C publication Critical patent/CA2285852C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA 2285852 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline Expired - Fee Related CA2285852C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2285852 CA2285852C (fr) 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2285852 CA2285852C (fr) 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline

Publications (2)

Publication Number Publication Date
CA2285852A1 CA2285852A1 (fr) 2000-01-04
CA2285852C true CA2285852C (fr) 2001-04-03

Family

ID=4164363

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2285852 Expired - Fee Related CA2285852C (fr) 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline

Country Status (1)

Country Link
CA (1) CA2285852C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462174B1 (en) 2001-06-25 2002-10-08 Astrazeneca Ab Amorphous compound
US6627760B1 (en) 2001-06-25 2003-09-30 Astrazeneca Ab Amorphous compound
US6458769B1 (en) 2001-06-25 2002-10-01 Astrazeneca Ab Amorphous compound

Also Published As

Publication number Publication date
CA2285852A1 (fr) 2000-01-04

Similar Documents

Publication Publication Date Title
KR100696350B1 (ko) 급속 방출 정제
US10307400B2 (en) Orally disintegrating tablet containing asenapine
KR20010024184A (ko) 활성 성분으로 클로드로네이트, 부형제로 실리시파이드미세결정성 셀룰로즈를 함유하는 의약 제제
EP1711168A2 (fr) Compositions pharmaceutiques orales de candesartan cilexetil
CA2662265A1 (fr) Compositions d'imatinib
US8193226B2 (en) Candesartan cilexetil
KR20010071765A (ko) 제약학적 레보타이록신 제제
JP2002515421A (ja) レボチロキシンナトリウム含有医薬製剤
ZA200409237B (en) Immediate release pharmaceutical formulation.
KR101230178B1 (ko) 골다공증 예방 또는 치료용 조성물 및 이의 제조방법
KR20050039732A (ko) 이부프로펜 결정의 형성 방법
CA2285852C (fr) Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline
JP2013544272A5 (fr)
EP2131817A2 (fr) Composition pharmaceutique de fumarate de quétiapine
US20030027837A1 (en) Pharmaceutical compositions comprising quinapril magnesium
WO2000071117A1 (fr) Compositions medicinales a liberation immediate pour administration orale
US7074429B2 (en) Fosinopril sodium tablet formulation
EP2303233A1 (fr) Forme galénique orale solide contenant l agent anti-plaquettaire clopidogrel et son procédé de préparation
JP2009091292A (ja) 保存安定性に優れた塩酸テモカプリルの錠剤
EP1567131A1 (fr) Formes pharmaceutiques solides a l'hydrochlorure de bupropione
US20020037858A1 (en) Pharmaceutical compositions comprising moexipril magnesium
KR100653388B1 (ko) 안정성이 우수한 ａｃｅ 저해제를 포함하는 약제학적 조성물
KR100679166B1 (ko) 안정성이 증진된 약제학적 조성물 및 그의 제조방법
US20070248665A1 (en) Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
EP2150240A1 (fr) Composition pharmaceutique à stabilité améliorée comprenant un inhibiteur de l'ace ou un de ses sels pharmacocompatibles, et leurs méthodes de fabrication

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed